IS1999B - 4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni - Google Patents

4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni

Info

Publication number: IS1999B
Authority: IS; Iceland
Prior art keywords: alkyl; tetrahydropyridine; aryl; phenylalkyl; neuromuscular
Prior art date: 1995-06-28

Application number

IS4641A

Other languages

English (en)

Other versions

IS4641A (is

Inventor

Badone Domenico

Baroni Marco

Cardamone Rosanna

Fournier Jacqueline

Guzzi Umberto

Ielmini Alessandra

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-28

Filing date

1997-12-23

Publication date

2005-04-15

1997-12-23 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

1997-12-23 Publication of IS4641A publication Critical patent/IS4641A/is

2005-04-15 Publication of IS1999B publication Critical patent/IS1999B/is

Links

230000000694 effects Effects 0.000 title 1
230000002232 neuromuscular Effects 0.000 title 1
239000002858 neurotransmitter agent Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
-1 phenoxy, phenylamino Chemical group 0.000 abstract 3
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 abstract 1
150000003863 ammonium salts Chemical class 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
125000005111 carboxyalkoxy group Chemical group 0.000 abstract 1
125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
125000006310 cycloalkyl amino group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
125000005504 styryl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IS4641A 1995-06-28 1997-12-23 4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni IS1999B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9507760A FR2736053B1 (fr)	1995-06-28	1995-06-28	Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1996/000995 WO1997001536A1 (fr)	1995-06-28	1996-06-26	4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines ayant une activite neurotrophique et neuroprotectrice

Publications (2)

Publication Number	Publication Date
IS4641A IS4641A (is)	1997-12-23
IS1999B true IS1999B (is)	2005-04-15

Family

ID=9480466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4641A IS1999B (is)	1995-06-28	1997-12-23	4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni

Country Status (29)

Country	Link
US (1)	US5981754A (is)
EP (2)	EP0837848B1 (is)
JP (2)	JP3147906B2 (is)
KR (1)	KR100460581B1 (is)
CN (1)	CN1153765C (is)
AT (1)	ATE223897T1 (is)
AU (1)	AU715090B2 (is)
BR (1)	BR9608662A (is)
CA (1)	CA2225746C (is)
CY (1)	CY2312B1 (is)
CZ (1)	CZ291075B6 (is)
DE (1)	DE69623631T2 (is)
DK (1)	DK0837848T3 (is)
EE (1)	EE03870B1 (is)
ES (1)	ES2183965T3 (is)
FR (1)	FR2736053B1 (is)
HU (1)	HUP9900055A3 (is)
IL (1)	IL122159A (is)
IS (1)	IS1999B (is)
NO (1)	NO310144B1 (is)
NZ (1)	NZ312723A (is)
PL (2)	PL187087B1 (is)
PT (1)	PT837848E (is)
RU (1)	RU2163237C2 (is)
SK (2)	SK283707B6 (is)
TR (1)	TR199701710T1 (is)
UA (1)	UA62914C2 (is)
WO (1)	WO1997001536A1 (is)
ZA (1)	ZA965527B (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2762514B1 (fr) *	1997-04-29	1999-10-22	Sanofi Sa	Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) *	1997-05-28	2003-06-06	Sanofi Sa	Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
CO4980891A1 (es) *	1997-11-14	2000-11-27	Sanofi Sa	Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
FR2771007B1 (fr) *	1997-11-14	2000-12-01	Sanofi Sa	Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR2771006B1 (fr) *	1997-11-14	2000-12-01	Sanofi Sa	Association de principes actifs pour le traitement de la demence senile du type alzheimer
WO1999065896A1 (en) *	1998-06-19	1999-12-23	Eli Lilly And Company	Preparation of heteroaryl compounds
FR2803593B1 (fr) *	2000-01-06	2002-02-15	Sanofi Synthelabo	Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2823748B1 (fr) *	2001-04-20	2004-02-20	Sanofi Synthelabo	Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
EP1383762B1 (fr)	2001-04-20	2007-06-20	Sanofi-Aventis	Tetrahydropyridyl-alkyl-heterocycles, procede pour leur preparation et compositions pharmaceutiques les contenants
FR2840896B1 (fr) *	2002-06-18	2005-04-08	Sanofi Synthelabo	Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
JP4616003B2 (ja) *	2002-12-16	2011-01-19	田辺三菱製薬株式会社	３−置換−４−ピリミドン誘導体
EP1657240A4 (en)	2003-08-18	2009-04-08	Fujifilm Finechemicals Co Ltd	PYRIDYLTETRAHYDROPYRIDINE, PYRIDYLPIPERIDINE AND METHOD FOR THE PRODUCTION THEREOF
TWI350168B (en) *	2004-05-07	2011-10-11	Incyte Corp	Amido compounds and their use as pharmaceuticals
EP1768954A4 (en) *	2004-06-24	2008-05-28	Incyte Corp	2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS
MXPA06014573A (es) *	2004-06-24	2007-03-12	Incyte Corp	Compuestos amido y su uso como farmaceuticos.
WO2006012226A2 (en) *	2004-06-24	2006-02-02	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
MXPA06014572A (es) *	2004-06-24	2007-03-12	Incyte Corp	Compuestos amido y su uso como farmaceuticos.
US20060009491A1 (en) *	2004-06-24	2006-01-12	Incyte Corporation	Amido compounds and their use as pharmaceuticals
EA200700251A1 (ru) *	2004-08-10	2007-08-31	Инсайт Корпорейшн	Амидосоединения и их применение в качестве фармацевтических средств
SG161261A1 (en) *	2004-11-10	2010-05-27	Incyte Corp	Lactam compounds and their use as pharmaceuticals
US8110581B2 (en)	2004-11-10	2012-02-07	Incyte Corporation	Lactam compounds and their use as pharmaceuticals
CN101103016A (zh) *	2004-11-18	2008-01-09	因塞特公司	11-β羟基类固醇脱氢酶1型抑制剂及其使用方法
FR2883285B1 (fr) *	2005-03-17	2007-05-18	Sanofi Aventis Sa	Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
JP4864342B2 (ja) *	2005-04-27	2012-02-01	北興化学工業株式会社	ビアリール化合物の製造方法
CA2621255A1 (en) *	2005-09-21	2007-04-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
EA200870019A1 (ru) *	2005-12-05	2008-12-30	Инсайт Корпорейшн	Лактамовые соединения и способы их применения
US7998959B2 (en) *	2006-01-12	2011-08-16	Incyte Corporation	Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
BRPI0707408A2 (pt) *	2006-01-31	2011-05-03	Incyte Corp	compostos de amido e seu uso como produtos farmacêuticos
WO2007101270A1 (en) *	2006-03-02	2007-09-07	Incyte Corporation	MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
US20070208001A1 (en) *	2006-03-03	2007-09-06	Jincong Zhuo	Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
JP2009535420A (ja) *	2006-05-01	2009-10-01	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプ１のモジュレーターとしてのテトラ置換ウレア
JP2009537564A (ja) *	2006-05-17	2009-10-29	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプＩの複素環阻害剤およびそれを用いる方法
CL2008001839A1 (es)	2007-06-21	2009-01-16	Incyte Holdings Corp	Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
WO2009086277A1 (en)	2007-12-20	2009-07-09	Envivo Pharmaceuticals, Inc.	Tetrasubstituted benzenes
KR101773070B1 (ko) *	2010-01-19	2017-09-12	바이엘 인텔렉쳐 프로퍼티 게엠베하	아릴 및 헤테로아릴아세트산 유도체의 제조방법
WO2018195649A1 (en) *	2017-04-26	2018-11-01	Alberta Research Chemicals Inc.	Substituted tetrahydropyridine derivatives as ido-1 inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0398578B1 (en) *	1989-05-17	1997-03-12	Pfizer Inc.	2-piperidino-1-alkanol derivatives as antiischemic agents
FR2650505B1 (fr) *	1989-08-07	1994-06-03	Midy Spa	Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) *	1990-05-22	1994-11-10	Sanofi Sa	Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) *	1991-12-02	1995-09-28	Richter Gedeon Vegyeszet	Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DE4325855A1 (de) *	1993-08-02	1995-02-09	Boehringer Ingelheim Kg	Neue Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

1995
- 1995-06-28 FR FR9507760A patent/FR2736053B1/fr not_active Expired - Fee Related
1996
- 1996-06-26 EP EP96924023A patent/EP0837848B1/fr not_active Expired - Lifetime
- 1996-06-26 PL PL96324216A patent/PL187087B1/pl not_active IP Right Cessation
- 1996-06-26 KR KR1019970709747A patent/KR100460581B1/ko not_active Expired - Fee Related
- 1996-06-26 CN CNB961950900A patent/CN1153765C/zh not_active Expired - Fee Related
- 1996-06-26 DE DE69623631T patent/DE69623631T2/de not_active Expired - Fee Related
- 1996-06-26 CA CA002225746A patent/CA2225746C/en not_active Expired - Fee Related
- 1996-06-26 JP JP50420697A patent/JP3147906B2/ja not_active Expired - Fee Related
- 1996-06-26 SK SK1781-97A patent/SK283707B6/sk unknown
- 1996-06-26 AT AT96924023T patent/ATE223897T1/de not_active IP Right Cessation
- 1996-06-26 US US08/973,712 patent/US5981754A/en not_active Expired - Fee Related
- 1996-06-26 NZ NZ312723A patent/NZ312723A/en unknown
- 1996-06-26 AU AU64619/96A patent/AU715090B2/en not_active Ceased
- 1996-06-26 TR TR97/01710T patent/TR199701710T1/xx unknown
- 1996-06-26 PL PL357052A patent/PL192353B1/pl not_active IP Right Cessation
- 1996-06-26 EP EP02006482A patent/EP1216996A3/fr not_active Withdrawn
- 1996-06-26 UA UA97126360A patent/UA62914C2/uk unknown
- 1996-06-26 SK SK593-2003A patent/SK285433B6/sk unknown
- 1996-06-26 RU RU98101492/04A patent/RU2163237C2/ru not_active IP Right Cessation
- 1996-06-26 WO PCT/FR1996/000995 patent/WO1997001536A1/fr not_active Ceased
- 1996-06-26 CZ CZ19974222A patent/CZ291075B6/cs not_active IP Right Cessation
- 1996-06-26 ES ES96924023T patent/ES2183965T3/es not_active Expired - Lifetime
- 1996-06-26 BR BR9608662A patent/BR9608662A/pt not_active IP Right Cessation
- 1996-06-26 HU HU9900055A patent/HUP9900055A3/hu unknown
- 1996-06-26 EE EE9700348A patent/EE03870B1/xx not_active IP Right Cessation
- 1996-06-26 DK DK96924023T patent/DK0837848T3/da active
- 1996-06-26 IL IL12215996A patent/IL122159A/en not_active IP Right Cessation
- 1996-06-26 PT PT96924023T patent/PT837848E/pt unknown
- 1996-06-28 ZA ZA965527A patent/ZA965527B/xx unknown
1997
- 1997-12-23 IS IS4641A patent/IS1999B/is unknown
- 1997-12-23 NO NO19976079A patent/NO310144B1/no unknown
2000
- 2000-07-31 JP JP2000231069A patent/JP3302351B2/ja not_active Expired - Fee Related
2003
- 2003-01-15 CY CY0300004A patent/CY2312B1/xx unknown

Also Published As

Publication number	Publication date
JPH11506118A (ja)	1999-06-02
ES2183965T3 (es)	2003-04-01
KR19990028431A (ko)	1999-04-15
PL192353B1 (pl)	2006-10-31
IL122159A0 (en)	1998-04-05
HK1014952A1 (en)	1999-10-08
IS4641A (is)	1997-12-23
IL122159A (en)	2001-06-14
NO310144B1 (no)	2001-05-28
SK283707B6 (sk)	2003-12-02
AU715090B2 (en)	2000-01-13
PL187087B1 (pl)	2004-05-31
CA2225746C (en)	2004-05-18
CN1189154A (zh)	1998-07-29
NO976079L (no)	1997-12-23
CZ422297A3 (cs)	1998-04-15
SK178197A3 (en)	1998-07-08
RU2163237C2 (ru)	2001-02-20
CN1153765C (zh)	2004-06-16
EE03870B1 (et)	2002-10-15
DK0837848T3 (da)	2003-01-06
MX9710472A (es)	1998-03-31
CA2225746A1 (en)	1997-01-16
HUP9900055A2 (hu)	1999-04-28
CZ291075B6 (cs)	2002-12-11
DE69623631T2 (de)	2003-08-07
ZA965527B (en)	1997-01-24
EP1216996A3 (fr)	2003-10-15
WO1997001536A1 (fr)	1997-01-16
EE9700348A (et)	1998-06-15
CY2312B1 (en)	2003-11-14
PL324216A1 (en)	1998-05-11
JP3147906B2 (ja)	2001-03-19
ATE223897T1 (de)	2002-09-15
NZ312723A (en)	1999-10-28
TR199701710T1 (xx)	1998-05-21
KR100460581B1 (ko)	2005-04-14
JP2001114763A (ja)	2001-04-24
DE69623631D1 (en)	2002-10-17
SK285433B6 (sk)	2007-01-04
EP0837848A1 (fr)	1998-04-29
EP1216996A2 (fr)	2002-06-26
NO976079D0 (no)	1997-12-23
HUP9900055A3 (en)	1999-11-29
EP0837848B1 (fr)	2002-09-11
AU6461996A (en)	1997-01-30
BR9608662A (pt)	1999-05-04
JP3302351B2 (ja)	2002-07-15
UA62914C2 (en)	2004-01-15
FR2736053A1 (fr)	1997-01-03
US5981754A (en)	1999-11-09
FR2736053B1 (fr)	1997-09-19
PT837848E (pt)	2002-12-31

Publication	Publication Date	Title
IS4641A (is)	1997-12-23	4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni
GR3029408T3 (en)	1999-05-28	Novel piperidine derivatives, useful as neurokinin receptor antagonists
IL115572A0 (en)	1996-01-19	Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them
NO914218L (no)	1992-04-30	Synergistiske ultrafiolettabsorberblandinger inneholdendehydroksyaryltriaziner og tetraalkylpiperidiner
AU3443595A (en)	1996-05-09	Benzylpiperidine derivatives
FR2757056B1 (fr)	2003-03-14	Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
GR861369B (en)	1986-09-29	Method for preparing quinoline's amides and medicaments containing them
TW341570B (en)	1998-10-01	Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
DK0958280T3 (da)	2005-08-29	Arylpiperidinopropanol- og arylpiperazinopropanolderivater og farmaceutiske midler der indeholder disse
ATE203021T1 (de)	2001-07-15	Verwendung von lactamverbindungen als pharmazeutische wirkstoffe
IL116387A (en)	2000-11-21	5-acyl-1,4-dihydropyridines for control of disorders of CNS with modulating action on potassium channels certain such novel compounds and their preparation
CY2274B1 (en)	2003-07-04	1-Phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
ATE192155T1 (de)	2000-05-15	Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
MX9801493A (es)	1998-08-30	Amidas del acido fluorbutenoico.